Innovate Pharmaceuticals ^Company

Innovate Pharmaceuticals is a research-based development stage pharmaceutical company that discovers and develops innovative medicines, including immunotherapy. Their candidate drug P1867B opens up the long-held hope that combinations of targeted agents can be used to precisely attacking the specific drivers of cancers. This form of personalised medicine allows us to offer not only a wide range of targeted drugs with low toxicity but at a cost that makes such combinations feasible. The company's goal is fighting cancer resistance. It leverages Innovate's proprietary supra-molecular chemistry platform to discover and design novel treatments in areas of unmet need.